Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1993 Dec;101(Suppl 5):163–168. doi: 10.1289/ehp.93101s5163

Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis.

G M Ledda-Columbano 1, P Coni 1, G Simbula 1, I Zedda 1, A Columbano 1
PMCID: PMC1519459  PMID: 8013404

Abstract

Liver cell proliferation has often been implicated to play a major role during different steps of the carcinogenic process. Most of the experimental studies indicating a close association between cell proliferation and liver cancer development have made use of a compensatory type of proliferative stimulus. However, liver growth may also be caused by direct hyperplasia after administration of primary mitogens. Our recent studies examined the possible differences between these two types of cell proliferation. Our studies indicate that a) increased expression of proto-oncogenes such as c-fos, c-jun, and c-myc is not necessary for entry into the cell cycle during mitogen-induced liver growth; b) mitogen-induced liver growth does not support initiation of chemical hepatocarcinogenesis; c) repeated proliferative stimuli induced by primary mitogens do not stimulate the growth of initiated cells to a focal and/or nodular stage; and d) mitogen-induced liver growth, unlike compensatory regeneration, is followed by a particular mode of cell death, namely, apoptosis. This type of cell death may be responsible for the elimination of carcinogen-initiated cells.

Full text

PDF
163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Gold L. S. Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7772–7776. doi: 10.1073/pnas.87.19.7772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cayama E., Tsuda H., Sarma D. S., Farber E. Initiation of chemical carcinogenesis requires cell proliferation. Nature. 1978 Sep 7;275(5675):60–62. doi: 10.1038/275060a0. [DOI] [PubMed] [Google Scholar]
  3. Chiu R., Boyle W. J., Meek J., Smeal T., Hunter T., Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 1988 Aug 12;54(4):541–552. doi: 10.1016/0092-8674(88)90076-1. [DOI] [PubMed] [Google Scholar]
  4. Columbano A., Ledda-Columbano G. M., Coni P. P., Faa G., Liguori C., Santa Cruz G., Pani P. Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest. 1985 Jun;52(6):670–675. [PubMed] [Google Scholar]
  5. Columbano A., Ledda-Columbano G. M., Coni P., Pani P. Failure of mitogen-induced cell proliferation to achieve initiation of rat liver carcinogenesis. Carcinogenesis. 1987 Feb;8(2):345–347. doi: 10.1093/carcin/8.2.345. [DOI] [PubMed] [Google Scholar]
  6. Columbano A., Ledda-Columbano G. M., Ennas M. G., Curto M., Chelo A., Pani P. Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis. 1990 May;11(5):771–776. doi: 10.1093/carcin/11.5.771. [DOI] [PubMed] [Google Scholar]
  7. Columbano A., Ledda-Columbano G. M., Lee G., Rajalakshmi S., Sarma D. S. Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res. 1987 Nov 1;47(21):5557–5559. [PubMed] [Google Scholar]
  8. Columbano A., Ledda-Columbano G. M., Rao P. M., Rajalakshmi S., Sarma D. S. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study. Am J Pathol. 1984 Sep;116(3):441–446. [PMC free article] [PubMed] [Google Scholar]
  9. Columbano A., Ledda G. M., Rao P. M., Rajalakshmi S., Sarma D. S. Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat. Cancer Lett. 1982 Jul-Aug;16(2):191–196. doi: 10.1016/0304-3835(82)90060-x. [DOI] [PubMed] [Google Scholar]
  10. Columbano A., Rajalakshmi S., Sarma D. S. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res. 1981 Jun;41(6):2079–2083. [PubMed] [Google Scholar]
  11. Coni P., Pichiri-Coni G., Ledda-Columbano G. M., Rao P. M., Rajalakshmi S., Sarma D. S., Columbano A. Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA. Carcinogenesis. 1990 May;11(5):835–839. doi: 10.1093/carcin/11.5.835. [DOI] [PubMed] [Google Scholar]
  12. Dragani T. A., Manenti G., Della Porta G. Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis. Cancer Lett. 1986 May;31(2):171–179. doi: 10.1016/0304-3835(86)90008-x. [DOI] [PubMed] [Google Scholar]
  13. Farber E., Parker S., Gruenstein M. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res. 1976 Nov;36(11 Pt 1):3879–3887. [PubMed] [Google Scholar]
  14. Fausto N., Mead J. E. Regulation of liver growth: protooncogenes and transforming growth factors. Lab Invest. 1989 Jan;60(1):4–13. [PubMed] [Google Scholar]
  15. Harling O. K. Boron neutron capture therapy: the role of peer review. Science. 1990 Aug 31;249(4972):972–973. [PubMed] [Google Scholar]
  16. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990 Oct 18;347(6294):645–650. doi: 10.1038/347645a0. [DOI] [PubMed] [Google Scholar]
  17. Kaufmann W. K., Rahija R. J., MacKenzie S. A., Kaufman D. G. Cell cycle-dependent initiation of hepatocarcinogenesis in rats by (+/-)-7r,8t-dihydroxy-9t,10t-epoxy-7,8,9,10-tetrahydrobenzo(a)py rene. Cancer Res. 1987 Jul 15;47(14):3771–3775. [PubMed] [Google Scholar]
  18. Kinoshita T., Tashiro K., Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1229–1234. doi: 10.1016/0006-291x(89)92733-2. [DOI] [PubMed] [Google Scholar]
  19. Kraupp-Grasl B., Huber W., Putz B., Gerbracht U., Schulte-Hermann R. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res. 1990 Jun 15;50(12):3701–3708. [PubMed] [Google Scholar]
  20. Ledda-Columbano G. M., Columbano A., Coni P., Faa G., Pani P. Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol. 1989 Oct;135(4):657–662. [PMC free article] [PubMed] [Google Scholar]
  21. Lindroos P. M., Zarnegar R., Michalopoulos G. K. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 1991 Apr;13(4):743–750. [PubMed] [Google Scholar]
  22. Marsman D. S., Cattley R. C., Conway J. G., Popp J. A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 1988 Dec 1;48(23):6739–6744. [PubMed] [Google Scholar]
  23. Miner J. N., Diamond M. I., Yamamoto K. R. Joints in the regulatory lattice: composite regulation by steroid receptor-AP1 complexes. Cell Growth Differ. 1991 Oct;2(10):525–530. [PubMed] [Google Scholar]
  24. Peraino C., Fry R. J., Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 1971 Oct;31(10):1506–1512. [PubMed] [Google Scholar]
  25. Perera M. I., Shinozuka H. Accelerated regression of carcinogen-induced preneoplastic hepatocyte foci by peroxisome proliferators, BR931, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio (N-B-hydroxyethyl)acetamide, and di-(2-ethylhexyl)phthalate. Carcinogenesis. 1984 Sep;5(9):1193–1198. doi: 10.1093/carcin/5.9.1193. [DOI] [PubMed] [Google Scholar]
  26. Pound A. W. Carcinogenesis and cell proliferation. N Z Med J. 1968 Jan;67(426 Suppl):88–99. [PubMed] [Google Scholar]
  27. Pound A. W., McGuire L. J. Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br J Cancer. 1978 Apr;37(4):585–594. doi: 10.1038/bjc.1978.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Preston-Martin S., Pike M. C., Ross R. K., Jones P. A., Henderson B. E. Increased cell division as a cause of human cancer. Cancer Res. 1990 Dec 1;50(23):7415–7421. [PubMed] [Google Scholar]
  29. Rabes H. M., Müller L., Hartmann A., Kerler R., Schuster C. Cell cycle-dependent initiation of adenosine triphosphatase-deficient populations in adult rat liver by a single dose of N-methyl-N-nitrosourea. Cancer Res. 1986 Feb;46(2):645–650. [PubMed] [Google Scholar]
  30. Rao M. S., Reddy J. K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis. 1987 May;8(5):631–636. doi: 10.1093/carcin/8.5.631. [DOI] [PubMed] [Google Scholar]
  31. Rotstein J., Sarma D. S., Farber E. Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Res. 1986 May;46(5):2377–2385. [PubMed] [Google Scholar]
  32. Tatematsu M., Nakanishi K., Murasaki G., Miyata Y., Hirose M., Ito N. Enhancing effect of inducers of liver microsomal enzymes on induction of hyperplastic liver nodules by N-2-fluorenylacetamide in rats. J Natl Cancer Inst. 1979 Dec;63(6):1411–1416. [PubMed] [Google Scholar]
  33. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  34. Yager J. D., Roebuck B. D., Paluszcyk T. L., Memoli V. A. Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. Carcinogenesis. 1986 Dec;7(12):2007–2014. doi: 10.1093/carcin/7.12.2007. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES